WP Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
3,208
+9
| +0.3% | +$4.01K | 0.39% | 41 |
|
|
2025
Q1 | $1.55M | Hold |
3,199
| – | – | 0.52% | 36 |
|
|
2024
Q4 | $1.29M | Hold |
3,199
| – | – | 0.43% | 43 |
|
|
2024
Q3 | $1.49M | Sell |
3,199
-845
| -21% | -$393K | 0.54% | 40 |
|
|
2024
Q2 | $1.9M | Sell |
4,044
-100
| -2% | -$46.9K | 0.61% | 36 |
|
|
2024
Q1 | $1.73M | Sell |
4,144
-70
| -2% | -$29.3K | 0.57% | 38 |
|
|
2023
Q4 | $1.71M | Sell |
4,214
-337
| -7% | -$137K | 0.63% | 34 |
|
|
2023
Q3 | $1.58M | Sell |
4,551
-34
| -0.7% | -$11.8K | 0.65% | 35 |
|
|
2023
Q2 | $1.61M | Sell |
4,585
-417
| -8% | -$147K | 0.65% | 34 |
|
|
2023
Q1 | $1.58M | Hold |
5,002
| – | – | 0.65% | 37 |
|
|
2022
Q4 | $1.44M | Sell |
5,002
-705
| -12% | -$204K | 0.65% | 36 |
|
|
2022
Q3 | $1.65M | Buy |
5,707
+18
| +0.3% | +$5.21K | 0.75% | 32 |
|
|
2022
Q2 | $1.6M | Hold |
5,689
| – | – | 0.7% | 32 |
|
|
2022
Q1 | $1.49M | Sell |
5,689
-50
| -0.9% | -$13.1K | 0.61% | 37 |
|
|
2021
Q4 | $1.26M | Sell |
5,739
-738
| -11% | -$162K | 0.52% | 44 |
|
|
2021
Q3 | $1.18M | Buy |
6,477
+3,002
| +86% | +$545K | 0.48% | 44 |
|
|
2021
Q2 | $701K | Buy |
3,475
+252
| +8% | +$50.8K | 0.29% | 55 |
|
|
2021
Q1 | $693K | Buy |
3,223
+1,333
| +71% | +$287K | 0.3% | 49 |
|
|
2020
Q4 | $447K | Buy |
+1,890
| New | +$447K | 0.22% | 64 |
|
|
2018
Q3 | – | Sell |
-50
| Closed | -$8K | – | 282 |
|
|
2018
Q2 | $8K | Buy |
+50
| New | +$8K | 0.01% | 234 |
|